Thomas Lynch
Fortune : 425 520 $ au 31/05/2026
Fortune : 425 520 $ au 31/05/2026
Thomas James Lynch is President & Director at Fred Hutchinson Cancer Research Center and Fred Hutchinson Cancer Center since 2020.
Director at The Schwartz Center for Compassionate Healthcare since 2014.
Independent Director at Foghorn Therapeutics, Inc. since 2022.
Non-Executive Director at Hummingbird Bioscience Pte Ltd. since 2021.
Independent Director at Natera, Inc. starting 2026.
Member of the American Society of Clinical Oncology, Inc., International Association for the Study of Lung Cancer, Washington State Academy of Sciences, and American Association for Cancer Research.
Former Chairman & Chief Executive Officer at Massachusetts General Physician's Organization, Inc. from 2015 to 2017.
Chairman at Kleo Pharmaceuticals, Inc. from 2019 to 2020.
Independent Director at Infinity Pharmaceuticals, Inc. from 2012 to 2014.
Director & Professor at Yale Cancer Center from 2009 to 2015.
Director at The Massachusetts General Hospital from 2015 to 2017.
Director at PearlPoint Cancer Support, Inc. Chief Scientific Officer & Executive VP at Bristol Myers Squibb Co. from 2017 to 2019.
Chief-Oncology Hematology at The General Hospital Corp.
from 2007 to 2009.
Professor-Medicine at Harvard Medical School from 2008 to 2009.
Professor at Yale School of Medicine from 2009 to 2015.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NATERA, INC. 0 % | 26/06/2026 | 1 905 ( 0 % ) | 425 520 $ | 31/05/2026 |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/10/2022 |
| NATERA, INC. | Directeur/Membre du Conseil | 03/06/2026 |
Washington State Academy of Sc
Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services The Washington State Academy of Sciences (WSAS) is an independent, nonpartisan, nonprofit scientific advisory organization established by the state legislature in 2005 to provide objective scientific and technical information to state policymakers, agencies, and the governor’s office. The private company is located in the US. WSAS mobilizes over 400 volunteer scientists from academia, industry, and government across diverse disciplines to conduct evidence-based assessments on issues such as clean energy, salmon recovery, transportation resilience, environmental contaminants, public health, and emerging technologies. It produces peer-reviewed reports, white papers, and convenes experts through workshops, symposia, and topical affinity groups to foster multidisciplinary collaboration. The academy supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and a planned science policy fellowship program. WSAS is guided by a board of directors and staffed by experts in science policy and communications, emphasizing expertise, objectivity, collaboration, inclusivity, and timely communication to promote science-informed decision-making. It engages with legislators and the public through newsletters, events, and legislative workshops, aiming to enhance the impact of scientific research on public policy, and is committed to diversity, equity, and inclusion. | Corporate Officer/Principal | - |
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 26/07/2021 |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center | President | 01/01/2020 |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | President | 01/02/2020 |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Corporate Officer/Principal | - |
| ░░░ ░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 21 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Provides research and testing services | Commercial Services |
Yale Cancer Center
Yale Cancer Center Hospital/Nursing ManagementHealth Services Provides treatment services for cancer patients | Health Services |
The Massachusetts General Hospital
The Massachusetts General Hospital Hospital/Nursing ManagementHealth Services Operates as a cancer care hospital | Health Services |
Massachusetts General Physician's Organization, Inc.
Massachusetts General Physician's Organization, Inc. Medical/Nursing ServicesHealth Services Operates as a multi-specialty medical firm | Health Services |
Natera, Inc.
Natera, Inc. BiotechnologyHealth Technology Engages in development and commercialization of molecular testing and technology services in the fields of women’s, oncology and organ health | Health Technology |
PearlPoint Cancer Support, Inc.
PearlPoint Cancer Support, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services for cancer patients | Commercial Services |
International Association for the Study of Lung Cancer
International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a global organization dedicated to the research and study of lung cancer. The company is based in Aurora, CO. With a focus on advancing the understanding and treatment of lung cancer, the IASLC brings together researchers, healthcare professionals, and advocates from around the world. Through collaboration and education, the organization aims to improve patient outcomes and reduce the global burden of lung cancer. | Commercial Services |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center | Health Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Schwartz Center for Compassionate Healthcare | |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Foghorn Therapeutics, Inc.
Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Kleo Pharmaceuticals, Inc.
Kleo Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops small molecule immunotherapies to treat patients with cancer as well as other life-threatening diseases | Commercial Services |
Hummingbird Bioscience Pte Ltd.
Hummingbird Bioscience Pte Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Washington State Academy of Sc
Washington State Academy of Sc Miscellaneous Commercial ServicesCommercial Services The Washington State Academy of Sciences (WSAS) is an independent, nonpartisan, nonprofit scientific advisory organization established by the state legislature in 2005 to provide objective scientific and technical information to state policymakers, agencies, and the governor’s office. The private company is located in the US. WSAS mobilizes over 400 volunteer scientists from academia, industry, and government across diverse disciplines to conduct evidence-based assessments on issues such as clean energy, salmon recovery, transportation resilience, environmental contaminants, public health, and emerging technologies. It produces peer-reviewed reports, white papers, and convenes experts through workshops, symposia, and topical affinity groups to foster multidisciplinary collaboration. The academy supports science education and the next generation of scientists through programs like the Washington Junior Academy of Sciences and a planned science policy fellowship program. WSAS is guided by a board of directors and staffed by experts in science policy and communications, emphasizing expertise, objectivity, collaboration, inclusivity, and timely communication to promote science-informed decision-making. It engages with legislators and the public through newsletters, events, and legislative workshops, aiming to enhance the impact of scientific research on public policy, and is committed to diversity, equity, and inclusion. | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national